oncology

News in brief: Psoriasis flares not a barrier to ICI treatment; Home chemo proves safe during pandemic; Improved prediction of PICC thrombosis in cancer patients

Psoriasis not a barrier to ICI treatment Flares of pre-existing psoriasis are fairly common in patients treated with immune checkpoint inhibitors for a range of cancers including melanoma. A study of 76 ICI-treated patients from the US, Australian and Germany found 57% experienced a flare of cutaneous or extracutaneous disease such as arthritis or iritis. ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic